respiratory

British Medical Association: Deadline 2 Mar 2018

 

J Moulton grant for research into asthma

Grant amount: £65,000

To assist research into asthma.

Applicants must be UK-registered medical practitioners or research scientists working in the UK.

For more information see the terms and conditions on the BMA website.

Advertisements

British Medical Association: Deadline 2 Mar 2018

 

H C Roscoe grant for research into viral diseases of the respiratory system

Grant amount: £50,000

To promote research into the elimination of the common cold and/or other viral diseases of the human respiratory system.

Applicants must be registered medical practitioners in the UK or research scientists working in the UK.

For more information see the terms and conditions on the BMA website.

 

 

Roy Castle Lung Cancer Foundation – Deadline: 12 Mar 2018

Early Detection or Patient Experience pilot and project grants

A. Early detection of lung cancer
Applications are invited for research projects into high risk population stratification and molecular screening.

B. Patient experience
We invite applications from professional groups, such as nurses and Allied Health Professionals who are very involved in the patient experience of lung cancer.


Types of Grants:

Pilot grants
These grants will not exceed 12 months duration and a maximum of £25,000 may be applied for. RCLCF pilot grants are available to allow established scientists to investigate and develop new ideas in the field of lung cancer research in the areas of Early Detection and Patient Experience. Pilot grants will be awarded if they can clearly demonstrate that support is for a new direction of research for researchers to test hypotheses to provide sufficient data for a full application to RCLCF. It is expected in general that a pilot grant will be used to fund a discrete piece of research that will not be supplemented from other sources. The applicant must have a proven track record in their own scientific field and be employed in a UK or Ireland university or research institute.

Project grants
These grants are awarded for up to two years and will not normally exceed £75,000 per annum. RCLCF’s projects grants are available to support innovative research in to lung cancer in the areas of Early Detection and Patient Experience. RCLCF will award project grants for a clear research proposal of relevance to RCLCF lung cancer research topics and is expected to lead to a significant advance of understanding of lung cancer and its impact. The applicants should have conducted independent research in the field of lung cancer or be an experienced researcher in a related field, and wish to build on their history and reputation in the lung cancer area, deepening their knowledge and experience.

For more information please visit the Roy Castle website.

MRC – Deadline: 14 Mar 2018

Biomedical Catalyst: Regenerative Medicine Research Committee

Supports translation of fundamental discoveries toward benefits to human health.

The translation of the burgeoning knowledge in regenerative medicine into new treatment strategies is a key objective of the MRC’s strategic plan. The Biomedical Catalyst: Regenerative Medicine Research Committee (RMRC) provides support for high quality proposals that may underpin or progress the development of  regenerative medicine therapies to improve human health. The RMRC:

  • Supports confidence in concept studies that if successful will promote the translation of fundamental discoveries toward benefits to human health, thereby accelerating the transition from discovery research to mature translational development projects
  • Funds preliminary work or feasibility studies to establish the viability of an approach, through addressing focussed research questions needed to unlock progress in pre-clinical development and/or early clinical testing of novel regenerative medicine therapies
  • Forms part of the MRC’s Translational Research Strategy and forms part of the Biomedical Catalyst funding stream, operating in conjunction with the Developmental Pathway Funding Scheme

For more information please visit the MRC website.

NIHR – Deadline: 20 Mar 2018

17/01 – 17/101 – Air pollution: outdoor air quality and health

 

The National Institute for Health Research invites stage 1 applications for its commissioned workstream, under the public health research programme. This supports research that evaluates public health interventions, providing new knowledge on the benefits, costs, acceptability and wider impacts of non-NHS interventions intended to improve the health of the public and reduce inequalities in health. The scope of the programme is multi-disciplinary and broad, covering a range of interventions that improve public health delivered in a non-NHS setting.

Researchers based in the UK may apply. Applicants are recommended to seek advice from suitable methodological support services, at an appropriate stage in the development of their research idea and application. Joint funding with other organisations is allowed. Proposals are expected to include active involvement of patients and the public in the research process.

There are no fixed limits on the duration of the projects or funding and proposals are expected to be tailored to fully address the problem.

For more information please visit the NIHR website.

NIHR – Deadline: 28 Mar 2018

HTA – commissioned work stream

The National Institute for Health Research invites stage 1 applications for its commissioned workstream, under the health technology assessment programme (HTA). This supports research on selected topics that are identified and prioritised to meet the needs of the NHS.

The programme aims to ensure that high quality research information on the effectiveness, costs and broader impact of health technology is produced in the most efficient way for those who use, manage, provide care in or develop policy for the NHS. Proposals are invited for primary research on the following topics: hyperosmolar therapy in traumatic brain injury; gastrointestinal side effects in cancer immune checkpoint therapy; joint distraction for knee osteoarthritis without alignment correction; intensive day patient versus inpatient treatment for anorexia nervosa in adult specialised eating disorder services; psychosocial intervention for internalised stigma to improve outcomes for people with schizophrenia; eye movement desensitisation and reprocessing for symptoms of post-traumatic stress disorder in adults with learning disabilities; selective serotonin reuptake inhibitor to prevent depression following traumatic brain injury; partial removal of dentinal caries in permanent teeth; sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease; exercise training for people with pulmonary hypertension; pre-pregnancy weight loss for women on long acting reversible contraception; intervention or expectant management for early onset fetal growth restriction in twin pregnancy; scanning laser ophthalmoscopy for diabetic eye screening; identification of older patients likely to require enhanced care on discharge from hospital; sepsis; dose of oxytocin during induction of labour and optimising the use of statin therapy in cardiovascular disease prevention.

Researchers based in the UK may apply. Applicants are recommended to seek advice from suitable methodological support service. Active involvement of patients and the public is expected where appropriate.

There are no fixed limits on the duration of projects or funding, and proposals should be tailored to fully address the research problem. All costs need to be fully justified to offer good value for money for the NHS. Funding may cover the costs of the research activity itself.

More information on these and other NIHR funding opportunities can be found here and on the links below:

17/128 – Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of COPD

17/140 – Optimising the use of statin therapy in cardiovascular disease prevention

17/129 – Exercise therapy for people with pulmonary hypertension

 

MRC – Deadline: 28 Mar 2018

Biomedical Catalyst: Developmental Pathway Funding Scheme (DPFS)

The DPFS scheme is a key part of our Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies.

Remit

The scheme supports academically led projects whose goals are to improve prevention, diagnosis, prognosis, or treatment of significant health needs, or that focus on developing research tools that increase the efficiency of developing interventions.

Projects supported by the scheme have up to four clearly defined milestones, outcomes and future plans. These help to maximise both the chance of success and the likelihood of the project attracting the downstream funding, from public or private sources, required to meet its clinical and commercial aims. The funding panels assessing the project will, if necessary, help to develop proposals and suggest enhancements.

The following activities are eligible for support:

  • Developing candidate therapeutic entities (e.g. drug discovery)
  • Pre-clinical testing of novel therapeutic entities
  • Early-phase clinical studies of novel therapeutic entities (phases 1 and 2)
  • “Repurposing” clinical studies – using existing therapies for new indications
  • Developing and testing novel devices
  • Developing and testing diagnostics (including biomarker validation)

Individual projects can start and finish at any point along the translational pathway but would not typically progress from initial development through to phase 2 clinical testing in a single application. Where there is a justified need for continued MRC support, sequential applications are encouraged.

All disease areas (including those relevant to global health) and modalities of intervention are eligible for support from the scheme, including small molecules, peptides, antibodies, vaccines, cell and gene therapy, devices, surgical techniques and psychological approaches.

 

For more information please visit the MRC website.

Association of Chartered Physiotherapists in Respiratory Care – Deadline: 31 Mar 18

Education and Development support

Members may request financial support to assist with their education and development. This would usually be a contribution towards a development opportunity where there is a substantial cost (several hundred pounds or more). Examples would be a contribution to funding a postgraduate degree module or to support the presentation of a member’s research at an international conference.

Applicants must be current members of the ACPRC and must have held membership for one year before applying. They must not have received financial support from ACPRC in the previous three years.

For more information please visit the ACPRC website.

Royal Society of Medicine – Deadline: 2 Apr 2018

Respiratory medicine section young investigator prize

Meeting date: Wednesday 17 October 2018
Prize: £500 trainee award; £250 student award + 1 year RSM membership
Open to: Both medical students and SpR/ST trainees

Applicants are invited to submit abstracts of less than 500 words on clinical or scientific research in which they are involved. Selected abstracts will be invited to present at the RSM to the Respiratory Section Council.

There will be one prize each for a medical student and a respiratory trainee. The student must be still studying and the trainee still in training at the time of application for the prize. The judging will be based on the contribution of the applicant, the originality, quality and scientific basis of the work.

For more information please visit the RSM website